NCT07259824

Brief Summary

This prospective, randomized, controlled, single-center clinical study aims to evaluate the effectiveness of the Serratus Posterior Superior Intercostal Plane Block (SPSIPB) in perioperative pain management among patients undergoing minimally invasive cardiac surgery (MICS). A total of 50 patients undergoing MICS will be randomized into two groups: one receiving standard analgesia plus ultrasound-guided SPSIPB with 30 mL of 0.25% bupivacaine, and a control group receiving standard analgesia only. The primary outcome is total postoperative opioid consumption within 24 hours. Secondary outcomes include postoperative pain scores, extubation time, block-related complications, and recovery parameters such as early mobilization, oral intake, Modified radiological atelectasis score and Quality of Recovery-15 scores.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 21, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

December 2, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

January 22, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 15, 2026

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 22, 2026

Completed
Last Updated

April 24, 2026

Status Verified

January 1, 2026

Enrollment Period

3 months

First QC Date

November 21, 2025

Last Update Submit

April 22, 2026

Conditions

Keywords

postoperative pain managementminimally invasive cardiac surgeryserratus posterior superior intercostal plane blockopioid consumption

Outcome Measures

Primary Outcomes (1)

  • Total opioid consumption within 24 hours after surgery

    The total amount of opioids (converted to intravenous morphine equivalent, mg) administered during the first 24 postoperative hours will be recorded from the patient-controlled analgesia (PCA) device and rescue analgesic doses.

    24 hours postoperatively

Secondary Outcomes (7)

  • Postoperative pain scores (NRS)

    6, 12, and 24 hours postoperatively

  • Extubation time

    Immediate postoperative period

  • Intraoperative opioid consumption

    During surgery

  • Block-related complications

    Within 24 hours postoperatively

  • Postoperative recovery parameters

    Within 48 hours postoperatively

  • +2 more secondary outcomes

Study Arms (2)

SPSIPB Group

EXPERIMENTAL

Patients in this group will receive ultrasound-guided Serratus Posterior Superior Intercostal Plane Block (SPSIPB) with 30 mL of 0.25% bupivacaine in addition to standard anesthesia and analgesia.

Procedure: Serratus Posterior Superior Intercostal Plane Block (SPSIPB)

Sham Block Group

SHAM COMPARATOR

Patients in this group will undergo the same ultrasound-guided block procedure using identical technique and needle placement, but 30 mL of normal saline will be injected instead of local anesthetic. All other anesthesia and analgesia protocols will be identical to the experimental group.

Procedure: Sham Serratus Posterior Superior Intercostal Plane Block

Interventions

The same ultrasound-guided procedure will be performed using identical technique and needle placement, but 30 mL of normal saline will be injected instead of local anesthetic. This sham block will be performed to maintain blinding, while all other anesthesia and analgesia protocols will be identical to the experimental group.

Sham Block Group

The SPSIPB will be performed under ultrasound guidance using an in-plane technique. The needle will be advanced into the fascial plane between the serratus posterior superior and intercostal muscles at the 2nd-3rd intercostal level, and 30 mL of 0.25% bupivacaine will be injected unilaterally on the surgical side. This procedure will be applied in addition to standard anesthesia and analgesia.

SPSIPB Group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients scheduled for elective minimally invasive cardiac surgery (MICS)
  • Age between 18 and 75 years
  • American Society of Anesthesiologists (ASA) physical status II-III
  • Body mass index (BMI) between 18 and 35 kg/m²
  • Patients who provide written informed consent for participation

You may not qualify if:

  • Known allergy or hypersensitivity to local anesthetics
  • Coagulopathy or current anticoagulant therapy
  • Pregnancy or breastfeeding
  • Impaired consciousness or inability to communicate
  • Failed or technically inadequate block
  • Refusal to undergo the block procedure
  • Cognitive or mental disorders preventing valid pain assessment
  • Opioid intolerance or contraindication to opioid use
  • Development of intraoperative or postoperative complications requiring reoperation, prolonged mechanical ventilation, or intensive care
  • Incomplete postoperative data or patient withdrawal from the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ankara Bilkent City Hospital

Ankara, 06800, Turkey (Türkiye)

Location

Related Publications (5)

  • Turan EI, Isik S, Baydemir AE, Sahin AS. Serratus posterior superior intercostal plane block for postoperative analgesia in clavicle surgeries: new indications for a novel block. Minerva Anestesiol. 2024 Nov;90(11):1058-1060. doi: 10.23736/S0375-9393.24.18275-2. Epub 2024 Aug 5. No abstract available.

    PMID: 39101308BACKGROUND
  • Avci O, Gundogdu O, Balci F, Tekcan MN, Ozbey M. Efficacy of serratus posterior superior intercostal plane block (SPSIPB) on post-operative pain and total analgesic consumption in patients undergoing video-assisted thoracoscopic surgery (VATS): A double-blinded randomised controlled trial. Indian J Anaesth. 2023 Dec;67(12):1116-1122. doi: 10.4103/ija.ija_589_23. Epub 2023 Dec 13.

    PMID: 38343684BACKGROUND
  • Shimizu C, Wakimoto M, Kita T. Efficacy of epidural anesthesia in minimally invasive cardiac surgery. Saudi J Anaesth. 2024 Oct-Dec;18(4):528-533. doi: 10.4103/sja.sja_334_24. Epub 2024 Oct 2.

    PMID: 39600439BACKGROUND
  • Dost B, Turunc E, Aydin ME, Kaya C, Aykut A, Demir ZA, Narayanan M, De Cassai A. Pain Management in Minimally Invasive Cardiac Surgery: A Review of Current Clinical Evidence. Pain Ther. 2025 Jun;14(3):913-930. doi: 10.1007/s40122-025-00739-1. Epub 2025 Apr 24.

    PMID: 40272720BACKGROUND
  • Piekarski F, Rohner M, Monsefi N, Bakhtiary F, Velten M. Anesthesia for Minimal Invasive Cardiac Surgery: The Bonn Heart Center Protocol. J Clin Med. 2024 Jul 5;13(13):3939. doi: 10.3390/jcm13133939.

    PMID: 38999504BACKGROUND

MeSH Terms

Conditions

Heart Valve Diseases

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Zeliha A Demir, M.D.

    Ankara Bilkent City Hospital, Department of Anesthesiology and Reanimation, Professor of Aneshesiology

    PRINCIPAL INVESTIGATOR
  • Aslıhan Aykut, M.D.

    Ankara Bilkent City Hospital, Department of Anesthesiology and Reanimation, Associate Professor of Anesthesiology

    STUDY DIRECTOR
  • Nisan Özsan, M.D.

    Ankara Bilkent City Hospital, Department of Anesthesiology and Reanimation

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
The anesthesiologist performing the block will be aware of group allocation, while the patients and the anesthesiologist responsible for postoperative data collection will remain blinded to the intervention. Pain assessments and other outcome measurements will be conducted by a blinded senior anesthesia resident who is unaware of which treatment each patient received.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a prospective, randomized, controlled, parallel-group clinical trial conducted at a single center. Eligible patients scheduled for minimally invasive cardiac surgery will be randomly assigned in a 1:1 ratio to receive either the Serratus Posterior Superior Intercostal Plane Block (SPSIPB) in addition to standard analgesia or standard analgesia alone. Both groups will be managed and evaluated under the same perioperative protocol, and outcomes will be assessed by blinded observers.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 21, 2025

First Posted

December 2, 2025

Study Start

January 22, 2026

Primary Completion

April 15, 2026

Study Completion

April 22, 2026

Last Updated

April 24, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

This is a single-center academic study. Individual participant data will not be shared publicly. Aggregate results will be reported in publication.

Locations